三諾生物(300298.SZ):擬向金融機構申請總額不超12億元的綜合授信額度
格隆匯4月6日丨三諾生物(300298.SZ)公佈,為加快公司發展,充分利用資金槓桿作用,提升公司盈利能力,為公司及股東創造更高價值,公司及子公司擬向包括相關銀行在內的金融機構申請總額不超過人民幣12億元的綜合授信額度,授信品種及用途包括但不限於貸款、銀行承兑匯票、信用證、貿易融資、票據貼現、應收賬款保理、各類保函等綜合業務。上述授信額度不等同於實際融資金額,公司及子公司根據實際資金需求及具體授信條件進行借貸,具體授信品種、授信額度及授信期限以最終合作金融機構實際審批並最終簽訂的協議為準。本次公司及子公司向金融機構申請綜合授信額度事項的授權有效期自公司2022年年度股東大會審議通過之日起至下一年年度股東大會召開之日止,授信額度可以循環滾動使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.